COMT Val158Met variant and functional haplotypes associated with childhood ADHD history in women with bulimia nervosa

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 4, 2011, Pages 948-952

  Yilmaz, Zeynep ^a,b   Kaplan, Allan S ^b,c,d   Zai, Clement C ^b,c   Levitan, Robert D ^b,c   Kennedy, James L ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Bulimia nervosa; Case control; Catechol O methyltransferase gene; Childhood ADHD; Family control; Haplotype

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BULIMIA; CASE CONTROL STUDY; CONTROLLED STUDY; FAMILY STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; RATING SCALE; RELATIVE; SINGLE NUCLEOTIDE POLYMORPHISM; WENDER UTAH RATING SCALE;

ADOLESCENT; ADULT; AGED; ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BULIMIA NERVOSA; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; CATECHOLAMINES; CHILD; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FAMILY; FEMALE; GENETIC MARKERS; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; MIDDLE AGED; PHENOTYPE; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; YOUNG ADULT;

EID: 79956016230     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.01.012     Document Type: Article

References (39)

1. Allen Brain Atlas Resources [Internet] 2010, Allen Institute for Brain Science, Seattle (WA), Available from:. http://www.brain-map.org.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, Author, Washington, DC. 4th ed.
3. Biederman J., Faraone S.V. Attention-deficit hyperactivity disorder. Lancet 2005, 9481:237-248.
4. Biederman J., Ball S.W., Monuteaux M.C., Surman C.B., Johnson J.L., Zeitlin S. Are girls with ADHD at risk for eating disorders? Results from a controlled, five-year prospective study. J Dev Behav Pediatr 2007, 28:302-307.
5. Bulik C.M., Sullivan P.F., Kendler K.S. Heritability of binge-eating and broadly defined bulimia nervosa. Biol Psychiatry 1998, 44:1210-1218.
6. Bulik C.M., Thornton L.M., Root T.L., Pisetsky E.M., Lichtenstein P., Pedersen N.L. Understanding the relation between anorexia nervosa and bulimia nervosa in a Swedish national twin sample. Biol Psychiatry 2010, 67:71-77.
7. Chen J., Lipska B.K., Halim N., Ma Q.D., Matsumoto M., Melhem S., et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004, 75:807-821.
8. Cortese S., Isnard P., Frelut M.L., Michel G., Quantin L., Guedeney A., et al. Association between symptoms of attention-deficit/hyperactivity disorder and bulimic behaviors in a clinical sample of severely obese adolescents. Int J Obes (Lond) 2007, 31:340-346.
9. Davis C., Levitan R.D., Smith M., Tweed S., Curtis C. Associations among overeating, overweight, and attention-deficit/hyperactivity disorder: a structural equation modeling approach. Eat Behav 2006, 7:266-274.
10. Davis C., Levitan R.D., Kaplan A.S., Carter J., Reid C., Curtis C., et al. Dopamine transporter gene (DAT1) associated with appetite suppression to methylphenidate in a case-control study of binge eating disorder. Neuropsychopharmacology 2007, 32:2199-2206.
11. Davis C., Levitan R.D., Kaplan A.S., Carter J., Reid C., Curtis C., et al. Reward sensitivity and the D2 dopamine receptor gene: a case-control study of binge eating disorder. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:620-628.
12. Davis C., Levitan R.D., Reid C., Carter J.C., Kaplan A.S., Patte K.A., et al. Dopamine for "wanting" and opioids for "liking": a comparison of obese adults with and without binge eating. Obesity 2009, 17:1220-1225.
13. Davis C., Patte K., Levitan R.D., Carter J., Kaplan A.S., Zai C., et al. A psycho-genetic study of associations between the symptoms of binge eating disorder and those of attention deficit (hyperactivity) disorder. J Psychiatr Res 2009, 43:687-696.
14. Fairburn C.G., Cooper Z. The eating disorder examination. Binge eating: nature, assessment and treatment 1993, 317-331. The Guildford Press, New York. 12th ed. C.G. Fairburn, G.T. Wilson (Eds.).
15. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV axis I disorders, research version - patient edition (SCID-I/P) 1995, Biometrics Research, New York State Psychiatric Institute, New York.
16. Fleming J., Levy L. Eating disorders in women with AD/HD. Gender issues and AD/HD: research, diagnosis, and treatment 2002, 411-426. Advantage Books, Silver Spring, MD. P.O. Quinn, K.G. Nadeau (Eds.).
17. Frieling H., Romer K.D., Scholz S., Mittelbach F., Wilhelm J., De Zwaan M., et al. Epigenetic dysregulation of dopaminergic genes in eating disorders. Int J Eat Disord 2010, 43:577-583.
18. Gizer I.R., Ficks C., Waldman I.D. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 2009, 126:51-90.
19. Halleland H., Lundervold A.J., Halmoy A., Haavik J., Johansson S. Association between catechol O-methyltransferase (COMT) haplotypes and severity of hyperactivity symptoms in adults. Am J Med Genet B Neuropsychiatr Genet 2009, 150:403-410.
20. Hosak L. Role of the COMT gene Val158Met polymorphism in mental disorders: a review. Eur Psychiatry 2007, 22:276-281.
21. Kang E.H., Song Y.J., Kim K.J., Shim H.B., Park J.E., Yu B.H. Sympathetic nervous function and the effect of the catechol-O-methyltransferase Val(158)Met polymorphism in patients with panic disorder. J Affect Disord 2010, 123:337-340.
22. Kaplan A.S., Levitan R.D., Yilmaz Z., Davis C., Tharmalingam S., Kennedy J.L. A DRD4/BDNF gene-gene interaction associated with maximum lifetime BMI in women with bulimia nervosa. Int J Eat Disord 2008, 41:22-28.
23. Kaplan A.S., Howlett A.L., Yilmaz Z., Levitan R. Attention deficit hyperactivity disorder and binge eating: shared phenomenology, genetics and response to treatment. Int J Child Adolesc Health 2009, 3:165-174.
24. Kapur S., Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 1996, 153:466-476.
25. Kaye W.H., Greeno C.G., Moss H., Fernstrom J., Fernstrom M., Lilenfeld L.R., et al. Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa. Arch Gen Psychiatry 1998, 55:927-935.
26. Kaye W.H., Frank G.K., Meltzer C.C., Price J.C., McConaha C.W., Crossan P.J., et al. Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa. Am J Psychiatry 2001, 158:1152-1155.
27. Lahiri D.K., Nurnberger J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991, 19:5444.
28. LaHoste G.J., Swanson J.M., Wigal S.B., Glabe C., Wigal T., King N., et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996, 1:121-124.
29. Levitan R.D., Kaplan A.S., Masellis M., Basile V.S., Walker M.L., Lipson N., et al. Polymorphism of the serotonin 5-HT1B receptor gene (HTR1B) associated with minimum lifetime body mass index in women with bulimia nervosa. Biol Psychiatry 2001, 50:640-643.
30. Levitan R.D., Masellis M., Lam R.W., Kaplan A.S., Davis C., Tharmalingam S., et al. A birth-season/DRD4 gene interaction predicts weight gain and obesity in women with seasonal affective disorder: a seasonal thrifty phenotype hypothesis. Neuropsychopharmacology 2006, 31:2498-2503.
31. Levitan R.D., Kaplan A.S., Davis C., Lam R.W., Kennedy J.L. A season-of-birth/DRD4 interaction predicts maximal body mass index in women with bulimia nervosa. Neuropsychopharmacology 2010, 35:1729-1733.
32. Matsumoto M., Weickert C.S., Akil M., Lipska B.K., Hyde T.M., Herman M.M., et al. Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience 2003, 116:127-137.
33. Mikołajczyk E., Smiarowska M., Grzywacz A., Samochowiec J. Association of eating disorders with catechol-O-methyltransferase gene functional polymorphism. Neuropsychobiology 2006, 54:82-86.
34. Nackley A.G., Shabalina S.A., Tchivileva I.E., Satterfield K., Korchynskyi O., Makarov S.S., et al. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 2006, 314:1930-1933.
35. Nyholt D.R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004, 74:765-769.
36. Robeva R., Penberthy J.K., Loboschefski T., Cox D., Kovatchev B. Combined psychophysiological assessment of ADHD: a pilot study of Bayesian probability approach illustrated by appraisal of ADHD in female college students. Appl Psychophysiol Biofeedback 2004, 29:1-18.
37. Sasaki-Adams D.M., Kelley A.E. Serotonin-dopamine interactions in the control of conditioned reinforcement and motor behavior. Neuropsychopharmacology 2001, 25:440-452.
38. Surman C.B., Randall E.T., Biederman J. Association between attention-deficit/hyperactivity disorder and bulimia nervosa: analysis of 4 case-control studies. J Clin Psychiatry 2006, 67:351-354.
39. Ward M.F., Wender P.H., Reimherr F.W. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993, 150:885-890.